实用肿瘤学杂志 ›› 2013, Vol. 27 ›› Issue (3): 206-210.doi: 10.3969/j.issn.1002-3070.2013.03.004

• 妇科肿瘤专栏 • 上一篇    下一篇

基于核磁及质谱分析技术的代谢组学在卵巢癌中的研究

葛婷婷,娄阁   

  1. 哈尔滨医科大学附属肿瘤医院妇一科(哈尔滨 150081)
  • 收稿日期:2012-12-10 出版日期:2013-06-28 发布日期:2013-07-04
  • 通讯作者: 娄阁,E-mail:dr-louge@163.com
  • 作者简介:葛婷婷,女,(1987-),硕士研究生,从事妇科肿瘤学的研究

NMR and mass spectrometry techniques based metabolomics in ovarian cancer research

GE Tingting,LOU Ge   

  1. Department of Gynecology,The Affiliated Tumor Hospital of Harbin Medical University,Harbin 10081,China
  • Received:2012-12-10 Online:2013-06-28 Published:2013-07-04

摘要: 卵巢癌是女性生殖器官恶性肿瘤中死亡率最高的疾病,早期无明显症状,70%的患者发现时已为晚期,所以卵巢癌的早发现、早治疗及个性化诊疗方案是肿瘤治疗的发展方向。代谢组学(Metabolomics)作为一种新兴技术为卵巢癌的早期诊断、疗效评价及预后判断打开了新窗口。在卵巢癌的发生发展过程中,机体产生不同的代谢产物,代谢组学能对机体代谢变化作出整体评价,筛选出有价值的生物标志物,用于肿瘤的早期诊断、治疗及预后评估。本文就代谢组学的概念和方法,代谢组学在卵巢癌的早期诊断、病理分型及靶向治疗的应用做一综述。

Abstract: Ovarian cancer is the highest mortality in the female genital malignancies.Because no obvious symptoms of early ovarian cancer,it is found 70% of patients with advanced.Therefore,early detection of ovarian cancer,early treatment and personalized treatment programs is the development direction of cancer treatment.Metabolomics as an emerging technology for the early diagnosis of ovarian cancer,the efficacy evaluation and prognosis has opened up a new window.Metabolomics can make a comprehensive evaluation of changes in metabolism,screened valuable biomarker for early diagnosis and treatment of tumors,treatment and prognosis.In this paper,we reviewed the concepts and Methods of metabolomics as well as metabolomics in the early diagnosis of ovarian cancer,pathological type and targeted therapy applications.

中图分类号: